Submit efficacy data of Indian population: CDSCO Panel Tells Eli Lilly for approval of additional indications of Ixekizumab Dr. Divya Colin9 Oct 2024 6:00 PM ISTNew Delhi: Citing that there is no efficacy data in the Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Emergency CS closely associated with women having psoriatic arthritis: BMJ Jacinthlyn Sylvia18 March 2023 9:30 AM ISTA new study published in BMJ Rheumatic & Musculoskeletal Diseases suggests that women with psoriatic arthritis (PsA) were more at risk for...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Women With Axial Spondyloarthritis have an increased risk of Pregnancy Complications: Study Dr. Shravani Dali7 April 2022 9:00 AM ISTWomen With Axial Spondyloarthritis have an increased risk of Pregnancy Complications, according to a study published in Seminars in Arthritis and...
CRP levels associated with slow radiographic progression in axial spondyloarthritis: study Dr. Shravani Dali15 Jan 2022 9:00 AM ISTEarly control of C-reactive protein levels with non-biologic is associated with slow radiographic progression in radiographic axial...
AI accurately detects radiographic sacroiliitis in axial spondyloarthritis Hina Zahid4 Jan 2021 3:30 PM ISTATLANTA -- New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that an artificial...
